Seqirus Contact Worldwide Directory WORLDWIDE DIRECTORY We have offices all around the world. Let us help you with your enquiry. Country UNITED KINGDOM ARGENTINA (LATAM) AUSTRALIA CANADA GERMANY ITALY NETHERLANDS NEW ZEALAND SEOUL (ASIA) SPAIN UNITED STATES SWITZERLAND Visit CSL Headquartered in Melbourne, Australia, CSL Limited includes: CSL Behring, incorporating CSL Plasma, and Seqirus. Contact CSL GBR-FLU-0006 February 2021 Report an Adverse Event To report a suspected side effect or adverse event, please visit our Report an Adverse Event page. Learn more Media Contacts Learn more Products If you would like further information on our products available around the world Learn more Report an Adverse Event Cookie Policy Privacy Notice Modern Slavery Terms of Use Sitemap © 2021 Seqirus. All rights reserved. Seqirus is a trademark of Seqirus UK Limited or its affiliates. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies

Seqirus Expertise In-licensing IN-LICENSING Seqirus has extensive experience in commercialising pharmaceutical and vaccine products for international partners in Australia and New Zealand. We offer a flexible partnering approach, with an ability to tailor licensing arrangements to meet the needs of our partners. We have a proven track record across a range of therapeutic areas and channels, including GP, specialist and hospital. In-licensing for Australia and New Zealand Our multi-award winning sales and marketing teams are recognised as leaders within the pharmaceutical industry. Seqirus is proud to have high performing primary and specialty care sales teams in Australia and New Zealand. With expertise in both private and reimbursed products, we can help you achieve your commercial goals. Contact for In-licensing Find out how Seqirus can help you enter the Australian and or New Zealand market by contacting our team. Email: PartneringAU@seqirus.com Strategic Market Entry Seqirus has dedicated regulatory and health economics team to secure optimum labelling and pricing in Australia and New Zealand markets Performance Driven Teams We have a robust track record building strong brands and achieving rapid market penetration in reimbursed and private markets in Australia and New Zealand. We Make it Our Own We make a significant investment and focus our resources during all phases of your product’s lifecycle. Partnering Flexibility Our team has a great ability to adapt to our partner’s needs. GBR-FLU-0006 February 2021 Our Company Seqirus is one of the largest influenza vaccine manufacturers in the world. Learn more R&D We focus on optimising our innovative technologies whilst also working on longer-term transformational approaches to influenza protection. Learn more Latest News Find out what’s happening at Seqirus Learn more Report an Adverse Event Cookie Policy Privacy Notice Modern Slavery Terms of Use Sitemap © 2021 Seqirus. All rights reserved. Seqirus is a trademark of Seqirus UK Limited or its affiliates.